DUTASTERIDE\TAMSULOSIN: 1,103 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
1,103
Total FAERS Reports
115 (10.4%)
Deaths Reported
255
Hospitalizations
1,103
As Primary/Secondary Suspect
32
Life-Threatening
14
Disabilities
First Report: 20000910 · Latest Report: 20250301
What Are the Most Common DUTASTERIDE\TAMSULOSIN Side Effects?
#1 Most Reported
Dizziness
101 reports (9.2%)
#2 Most Reported
Hypotension
82 reports (7.4%)
#3 Most Reported
Urinary retention
80 reports (7.3%)
All DUTASTERIDE\TAMSULOSIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dizziness | 101 | 9.2% | 3 | 32 |
| Hypotension | 82 | 7.4% | 1 | 17 |
| Urinary retention | 80 | 7.3% | 0 | 7 |
| Drug ineffective | 67 | 6.1% | 1 | 8 |
| Death | 61 | 5.5% | 61 | 4 |
| Fall | 47 | 4.3% | 12 | 19 |
| Gait disturbance | 43 | 3.9% | 0 | 2 |
| Cerebral hypoperfusion | 41 | 3.7% | 0 | 0 |
| Atrial fibrillation | 39 | 3.5% | 0 | 18 |
| Prostate cancer | 38 | 3.5% | 4 | 5 |
| Speech disorder | 38 | 3.5% | 2 | 2 |
| Constipation | 37 | 3.4% | 0 | 2 |
| Dysphagia | 36 | 3.3% | 0 | 12 |
| Dyspnoea | 33 | 3.0% | 0 | 9 |
| Syncope | 33 | 3.0% | 0 | 15 |
| Condition aggravated | 32 | 2.9% | 3 | 9 |
| Hypomagnesaemia | 32 | 2.9% | 0 | 16 |
| Malaise | 32 | 2.9% | 2 | 11 |
| Feeling cold | 30 | 2.7% | 0 | 0 |
| Acute kidney injury | 29 | 2.6% | 23 | 5 |
Who Reports DUTASTERIDE\TAMSULOSIN Side Effects? Age & Gender Data
Gender: 1.8% female, 98.2% male. Average age: 73.4 years. Most reports from: BR. View detailed demographics →
Is DUTASTERIDE\TAMSULOSIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2006 | 4 | 0 | 1 |
| 2010 | 5 | 0 | 1 |
| 2011 | 1 | 0 | 0 |
| 2012 | 4 | 0 | 0 |
| 2013 | 27 | 0 | 5 |
| 2014 | 71 | 5 | 25 |
| 2015 | 88 | 5 | 30 |
| 2016 | 41 | 5 | 7 |
| 2017 | 43 | 1 | 10 |
| 2018 | 56 | 24 | 17 |
| 2019 | 44 | 1 | 9 |
| 2020 | 31 | 2 | 10 |
| 2021 | 47 | 4 | 7 |
| 2022 | 25 | 2 | 13 |
| 2023 | 19 | 0 | 8 |
| 2024 | 28 | 0 | 22 |
| 2025 | 3 | 0 | 1 |
What Is DUTASTERIDE\TAMSULOSIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 526 |
| Benign prostatic hyperplasia | 313 |
| Prostatomegaly | 83 |
| Prostatic disorder | 60 |
| Prostate cancer | 10 |
| Dysuria | 9 |
| Prostatic specific antigen increased | 7 |
| Urinary retention | 7 |
DUTASTERIDE\TAMSULOSIN vs Alternatives: Which Is Safer?
DUTASTERIDE\TAMSULOSIN vs DUVELISIB
DUTASTERIDE\TAMSULOSIN vs DYDROGESTERONE
DUTASTERIDE\TAMSULOSIN vs EBASTINE
DUTASTERIDE\TAMSULOSIN vs ECALLANTIDE
DUTASTERIDE\TAMSULOSIN vs ECONAZOLE
DUTASTERIDE\TAMSULOSIN vs ECULIZUMAB
DUTASTERIDE\TAMSULOSIN vs EDARAVONE
DUTASTERIDE\TAMSULOSIN vs EDETATE
DUTASTERIDE\TAMSULOSIN vs EDOXABAN
DUTASTERIDE\TAMSULOSIN vs EDOXABAN TOSILATE
Official FDA Label for DUTASTERIDE\TAMSULOSIN
Official prescribing information from the FDA-approved drug label.